금융 뉴스 허브
실시간 글로벌 금융 시장 뉴스 · 분석 · 인사이트
BREAKING주요 뉴스
Trump envoys to hold fresh Ukraine talks as energy crunch looms over midterms
Steve Witkoff and Jared Kushner expected to travel to Norway to meet Volodymyr Zelenskyy...
Trump administration has not approved transfer of interceptor missiles to Ukraine
The US President Donald Trump administration has not approved the transfer of interceptor missiles ...
Iran’s IRGC warns blockade could extend to the Bab al-Mandeb Strait and the Suez Canal
Iran’s Islamic Revolutionary Guard Corps (IRGC) said on Monday that Tehran has not yet completely cl...
Why Is Prestige Consumer Healthcare (PBH) Up 3.6% Since Last Earnings Report?
Prestige Consumer Healthcare (PBH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why Is Vishay (VSH) Up 54.3% Since Last Earnings Report?
Vishay (VSH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why Is Manulife (MFC) Up 6% Since Last Earnings Report?
Manulife (MFC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why Is Grocery Outlet (GO) Up 22.8% Since Last Earnings Report?
Grocery Outlet (GO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
CarMax, In Turnaround Mode, Scores Breakout Before Earnings; AI Investors Eye Jabil Results
CarMax stock is in turnaround mode with a new CEO ahead of its upcoming earnings report, while AI investors await earnings from Jabil.
GraniteShares YieldBOOST Single Stock Universe ETF declares $0.1366 dividend
GraniteShares YieldBOOST TopYielders ETF declares $0.1352 dividend
My company fired one manager and is doing an ‘organizational reshuffling.’ Am I in trouble?
“They let go of a pretty high-up manager who they only hired a month ago.”
CVS Health (CVS): Buy, Sell, or Hold Post Q1 Earnings?
Over the past six months, CVS Health has been a great trade, beating the S&P 500 by 20%. Its stock price has climbed to $100.39, representing a healthy 26.4% increase. This was partly thanks to its so ...
Guardant rated new Outperform at RBC on catalysts, growth prospects
3 Reasons to Sell BALL and 1 Stock to Buy Instead
Ball trades at $56.29 per share and has stayed right on track with the overall market, gaining 10.6% over the last six months. At the same time, the S&P 500 has returned 6.4%.
Veeva Expands Safety Suite Footprint With UCB Pharmacovigilance Deal
VEEV's UCB pharmacovigilance deal expands Safety Suite adoption, supporting automation, compliance and long-term growth opportunities.